Quoin Pharmaceuticals Ltd... (QNRX)

AI Score

Unlock

6.64

0.08 (1.22%)

At close: Apr 24, 2025, 3:58 PM

6.85

3.10%

After-hours: Apr 24, 2025, 07:46 PM EDT

Quoin Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020	Q4 2019	Q4 2018	Q4 2017	Q4 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	3.62B	3.12M	2.85M	1.83M	2.4M	3.16M	4.76M	3.37M	2.86M	5.25M	2.69M	5.19M	7.48M	652.79K	1.72M	1.08M	323.83K	n/a	18.11M	13.73M	6.28M	1.63M
Short-Term Investments	10.43M	7.19M	9.73M	12.86M	8.29M	10.82M	10.68M	13.62M	9.99M	9.91M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	114.16K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	300M	383.39K	300K	300K	300K	300K	383.39K	383.39K	383.39K	50K	50K	50K	50K	50K	50K	245.66K	-1.94M	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	77.3K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-350.16K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	11.3B	190.54K	10.38M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	305.92K	253.15K	n/a	141.34K	n/a	n/a	n/a	n/a	n/a
Total Current Assets	14.93B	10.5M	13.22M	15.26M	11.29M	14.14M	15.67M	17.39M	13.37M	15.66M	3.51M	6M	8.5M	958.71K	2.02M	1.13M	465.17K	n/a	18.11M	13.73M	6.28M	1.63M
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	475.68K	n/a	1.94M	n/a	2.32M	1.34M	1.37M	357K
Goodwill & Intangibles	483.33M	508.33K	533.33K	558.33K	583.33K	626.53K	652.54K	678.55K	704.56K	730.57K	756.58K	782.59K	808.6K	834.62K	860.63K	886.64K	912.65K	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	783.33M	891.72K	833.34K	858.34K	883.34K	926.53K	1.04M	1.06M	1.09M	780.57K	806.58K	832.59K	858.6K	884.62K	910.63K	1.13M	912.65K	n/a	2.32M	1.34M	1.37M	357K
Total Assets	15.71B	11.39M	14.05M	16.12M	12.17M	15.07M	16.71M	18.45M	14.46M	16.44M	4.32M	6.83M	9.36M	1.84M	2.93M	2.26M	1.38M	n/a	21.32M	30.37M	33.91M	8.82M
Account Payables	905.7K	222.64K	819.67K	358.51K	526.52K	239.98K	707.93K	281.09K	605.6K	280.7K	768.67K	214.68K	923.24K	517.79K	403.81K	234.87K	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	-600K	-600K	-600	-600	-725	-650	-600	-600	-600	-600K	-736.44M	6.8M	165.23K	1.00	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	600K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	600K	743.84M	6.21M	6.21M	3.21M	1.21M	n/a	396K	n/a	n/a	n/a
Other Current Liabilities	3.28B	679.95K	690.78K	77.14K	694.01K	765.61K	924.41K	803.55K	759.59K	753.55K	753.55K	200K	-742.62M	1.4M	1.4M	2.9M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	4.18B	3.47M	3.95M	4.22M	3.58M	4.58M	4.41M	4.16M	3.53M	3.6M	3.67M	3.59M	8.7M	13.57M	13.11M	10.32M	7.99M	n/a	396K	n/a	n/a	n/a
Long-Term Debt	n/a	n/a	2.62M	2.77M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.97M	4.12M	n/a	n/a	2.45M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.32B	2.47M	n/a	19.00	2.92M	3.07M	3.22M	3.37M	3.52M	3.67M	3.82M	n/a	7.03B	4.52M	4.61M	n/a	n/a	n/a	-196K	n/a	n/a	n/a
Total Long-Term Liabilities	2.32B	2.47M	2.62M	2.77M	2.92M	3.07M	3.22M	3.37M	3.52M	3.67M	3.82M	3.97M	7.03B	4.52M	4.67M	2.45M	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	6.5B	5.95M	6.58M	7M	6.51M	7.65M	7.64M	7.54M	7.05M	7.27M	7.49M	7.56M	8.7M	18.1M	17.78M	12.77M	7.99M	n/a	396K	n/a	n/a	n/a
Total Debt	n/a	n/a	3.22M	3.37M	3.52K	3.67K	3.95K	4.02K	4.12K	4.27K	4.42K	4.57M	743.84M	6.21M	6.21M	5.66M	1.21M	n/a	396K	n/a	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.00	n/a	n/a	n/a	100.00	100.00	100.00	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-55.17B	-52.85M	-50.5M	-48.53M	-46.2M	-44.15M	-42.23M	-40.12M	-37.52M	-35.52M	-32.42M	-29.75M	-28.07M	-16.25M	-14.85M	-10.51M	-6.61M	n/a	-100.86M	n/a	n/a	n/a
Comprehensive Income	n/a	n/a	n/a	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00	0.00	0.00	n/a	5.2M	n/a	n/a	-4.51M	n/a	n/a	n/a	n/a
Shareholders Equity	9.2B	5.44M	7.48M	9.13M	5.66M	7.41M	9.07M	10.91M	7.41M	9.17M	-3.17M	-729.41K	657.03K	-16.25M	-14.85M	-10.51M	-6.61M	-4.51M	n/a	18.85M	28.49M	7.41M
Total Investments	10.43M	7.19M	9.73M	12.86M	8.29M	10.82M	10.68M	13.62M	9.99M	9.91M	n/a	n/a	n/a	n/a	114.16K	n/a	n/a	n/a	n/a	n/a	n/a	n/a